Phong Quang Selected Research

Phong Quang Research Topics

Disease

13	Neoplasms (Cancer) 01/2021 - 01/2010
7	Waldenstrom Macroglobulinemia (Macroglobulinemia) 01/2012 - 01/2010
3	Multiple Myeloma 01/2013 - 12/2011
2	Prostatic Neoplasms (Prostate Cancer) 01/2018 - 01/2017
2	Neoplasm Metastasis (Metastasis) 06/2012 - 01/2012
1	Inflammation (Inflammations) 01/2013
1	B-Cell Chronic Lymphocytic Leukemia (Chronic Lymphocytic Leukemia) 08/2012
1	Hypoxia (Hypoxemia) 06/2012
1	Hematologic Neoplasms (Hematological Malignancy) 07/2011
1	Lymphoma (Lymphomas) 04/2011
1	B-Cell Lymphoma (Lymphoma, B Cell) 02/2011

Drug/Important Bio-Agent (IBA)

2	5'-methylthioadenosine phosphorylase (methylthioadenosine nucleosidase)IBA 01/2021 - 04/2016
2	PolyaminesIBA 01/2018 - 01/2017
2	Mechanistic Target of Rapamycin Complex 1IBA 01/2017 - 12/2011
2	Antineoplastic Agents (Antineoplastics)IBA 04/2011 - 05/2010
2	Chymotrypsin FDA Link 04/2011 - 05/2010
2	Immunoglobulin M (IgM)IBA 04/2011 - 02/2011
2	Proteasome Endopeptidase Complex (Proteasome)IBA 04/2011 - 05/2010
2	Histones (Histone)IBA 02/2011 - 09/2010
2	MicroRNAs (MicroRNA)IBA 02/2011 - 09/2010
1	Messenger RNA (mRNA)IBA 01/2021
1	Methionine AdenosyltransferaseIBA 01/2021
1	EnzymesIBA 01/2021
1	S-Adenosylmethionine (Ademetionine)IBA 01/2021
1	Cyclin-Dependent Kinase Inhibitor p16IBA 01/2021
1	S-adenosyl-3-methylthiopropylamineIBA 01/2017
1	Phospholipase DIBA 09/2014
1	Tumor Necrosis Factor Receptors (Tumor Necrosis Factor Receptor)IBA 01/2013
1	GlucocorticoidsIBA 01/2013
1	OligonucleotidesIBA 08/2012
1	locked nucleic acidIBA 08/2012
1	Cadherins (E-Cadherin)IBA 06/2012
1	Proteins (Proteins, Gene)FDA Link 06/2012
1	P-SelectinIBA 02/2012
1	Glycoproteins (Glycoprotein)IBA 02/2012
1	LigandsIBA 02/2012
1	Eph Family Receptors (Eph Receptors)IBA 01/2012
1	Ephrin-B2 (Ephrin B2)IBA 01/2012
1	Mechanistic Target of Rapamycin Complex 2IBA 12/2011
1	Sirolimus (Rapamycin)FDA Link 12/2011
1	Type 3 Fibroblast Growth Factor Receptor (Fibroblast Growth Factor Receptor 3)IBA 07/2011
1	4- amino- 5- fluoro- 3- (5- (4- methylpiperazin- 1- yl)- 1H- benzimidazol- 2- yl)quinolin- 2(1H)- oneIBA 07/2011
1	carfilzomibIBA 04/2011
1	Bortezomib (Velcade)FDA Link 05/2010
1	TOR Serine-Threonine KinasesIBA 01/2010

Therapy/Procedure

4	Therapeutics 01/2021 - 01/2010